Combined Targeting of the BRD4-NUT-p300 Axis in NUT Midline Carcinoma by Dual Selective Bromodomain Inhibitor, NEO2734 von Morrison-Smiths, Chevaun D., Knox, Tatiana M., Filic, Ivona, Soroko, Kara M., Eschle, Benjamin K., Wilkens, Margaret K., Gokhale, Prafulla C., Giles, Francis, Griffin, Andrew, Browns, Bill, Shapiro, Geoffrey, Zucconi, Beth E., Cole, Philip A., Lemieuxs, Madeleine E., French, Christopher A.

Volltext

Abstract B014: Novel dual BET/p300 bromodomain inhibitors therapeutically inhibit BRD4-NUT driven NUT Carcinomas von Morrison-Smith, Chevaun D, DiBona, Amy, Walsh, Erica, Danga, Kristina, Filic, Ivona, Knox, Tatiana, Grayson, Adlai, Cameron, Michael, French, Christopher

Volltext

Chemical Screen Identifies Diverse and Novel Histone Deacetylase Inhibitors as Repressors of NUT Function: Implications for NUT Carcinoma Pathogenesis and Treatment von Shiota, Hitoshi, Alekseyenko, Artyom A., Wang, Zhipeng A., Filic, Ivona, Knox, Tatiana M., Luong, Nhi M., Huang, Yeying, Scott, David A., Jones, Kristen L., Gokhale, Prafulla C., Lemieux, Madeleine E., Cole, Philip A., Kuroda, Mitzi, French, Christopher A.

Volltext